Clinical Trial Update: Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial) [Phase 4]

View source ↗

Summary

The SCALOP trial is a Phase 4 study comparing octreotide versus splenic artery ligation to modulate portal flow in living donor liver transplants. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small-for-size Syndrome

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Small-for-Size Syndrome | Phase 4 | Status: NOT_YET_RECRUITING